Teclison
Business Services · Taiwan · 1-10 Employees
View Company Info for Free
Overview
Headquarters
10f No.124 Sec. 2 Nanjing East Rd, Taipe...Website
www.teclison.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Teclison
Teclison is a clinical-stage biotechnology company developing innovative cancer therapeutics to induce tumor necrosis and enhance anti-tumor immunity. Teclison was founded in 2014 and is based in Taiwan.Explore more
Teclison Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Teclison your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Teclison
Product Launch: Get notified when Teclison launches new products
Check if Teclison has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Teclison recently announced quarterly report
Teclison, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Teclison has new funding data
Check out if Teclison is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Teclison had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Teclison as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Teclison is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Teclison is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Teclison.
Teclison financials insights
Gather financial insights about Teclison, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Unspecified
$5.9M
Teclison Tech Stack
A closer look at the technologies used by Teclison
See more technologies
Most Recent Scoops
Person-Based
Events, Medical Research, Pharmaceuticals
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Teclison News & Media
Teclison, Inc. to Participate in Upcoming Investor Conference
Teclison will present in the MedInvest Biotech + Pharma Investor Conference March 27, 2025 at 2:05pm ETHypoxia Market Growing Significantly, Assesses DelveInsight | Teclison Ltd., Merck, Eli Lilly and Company, Reven Pharmaceuticals, Biogen Expected to Boost Hypoxia Market
The dynamics of the hypoxia market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending across the world, and also due to the expected launch of many therapies during the forecast period. The dynamics of the hypoxia market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending across the world, and also due to theTeclison Announces Publication of Phase 1 Data Demonstrating the Safety and Therapeutic Potential of Tirapazamine Chemoembolization for Patients with Unresectable Liver Cancer
— Tirapazamine (TPZ) with conventional trans-arterial chemoembolization had a good safety profile and promising efficacy signals in early- and intermediate-stage liver cancer, including in patients who had progression or recurrence after standard therapy —Teclison Completes $5.9M Funding
PRINCETON, NJ, Teclison, a clinical-stage biotechnology, announced the completion of a $5.9 million funding, led by W.T.T. Investment.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Teclison
Sign Up For FreeTo access detailed company insights
Teclison is a clinical-stage biotechnology company developing innovative cancer therapeutics to induce tumor necrosis and enhance anti-tumor immunity. Teclison was founded in 2014 and is based in Taiwan.... Read More
